Atypical Teratoid/Rhabdoid Tumors: Current Chemotherapy and Future Directions




40.

Kosaka C, Sasaguri T, Komiyama Y et al (2001) All-trans retinoic acid inhibits vascular smooth muscle cell proliferation targeting multiple genes for cyclins and cyclin dependent kinases. Hypertens Res 24:579–588CrossRefPubMed


41.

Li Y, Shen Q, Kim HT et al (2011) The rexinoid bexarotene represses cyclin D1 transcription by inducing the DEC2 transcriptional repressor. Breast Cancer Res Treat 128:667–677CrossRefPubMedCentralPubMed


42.

Lee S, Cimica V, Ramachandra N et al (2011) Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival. Cancer Res 71:3225–3235CrossRefPubMed


43.

Maris JM, Morton CL, Gorlick R et al (2010) Initial testing of the aurora kinase A inhibitor MLN 8237 by the Pediatric Preclinical Testing Program (PPTP). Pediatr Blood Cancer 55:26–34PubMedCentralPubMed

Jun 22, 2017 | Posted by in NEUROSURGERY | Comments Off on Atypical Teratoid/Rhabdoid Tumors: Current Chemotherapy and Future Directions

Full access? Get Clinical Tree

Get Clinical Tree app for offline access